Disruptive Innovation in Healthcare Conference discusses impact of innovation on healthcare system

The conference was held in MBRU in Dubai Healthcare City

  

DUBAI, UAE: Under the patronage of Chairperson of Dubai Healthcare City Authority (DHCA) HRH Princess Haya Bint Al Hussein, wife of HH Sheikh Mohammed Bin Rashid Al Maktoum, Vice-President and Prime Minister of the UAE and Ruler of Dubai, the Disruptive Innovation in Healthcare Conference, organised by Mediclinic Middle East in collaboration with Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), took place yesterday, September 18th. The conference was held in MBRU in Dubai Healthcare City, and saw the attendance of more than 200 healthcare professionals, senior managers, regulators, academicians, insurers and physicians from across the UAE’s healthcare sector. Following an introductory address by Professor Ian Greer, President and Vice Chancellor of Queen’s University Belfast, MBRU’s academic partner, who spoke about innovation in academic medicine, the conference heard from an impressive line-up of distinguished speakers from the UAE and across the globe, and provided an unparalleled platform to discuss the vast ranges of innovation in healthcare.

Amongst the panelists, His Excellency Khalfan Belhoul, Chief Executive Officer of Dubai Future Foundation was present and Dr. Mohammad Al Redha, Director of The Executive Office for Organizational Transformation, Dubai Health Authority who chaired the first session. The second and third sessions were chaired by MBRU’s Dean of the College of Medicine Professor Alawi Alsheikh-Ali as well as MBRU’s Associate Dean for Innovation and the Future, Professor Homero Rivas, consecutively.

Among the conference faculty were Paul Bessems, Chief Executive Officer, Weconet Technologies on the subject of Blockchain; Dr Niti Pall, Medical Director to the Global Health Practice, KPMG Center for Universal Health Coverage, who discussed the redesign of incentives; Dr Amjad Zaim, Chief Executive Officer, Cognitro Analytics, who tackled the issue of artificial intelligence in healthcare; Krishna G V. Giri, Co-Founder and Chief Executive Officer, Dhiyah Consulting, on the use of cutting edge technologies such as virtual reality in healthcare;; Dr Joel Diamond, Chief Medical Officer and Co-Founder, 2bPrecise, who talked about precision medicine; Anna-Lisa Silvestre, Patient Engagement Consultant, who presented on how to engage patients in a digital world; and Trip Allport, Managing Director, Africa Resource Centre, who revealed how simple, not complicated, innovation solutions could help resolve long standing health access problems in Africa.

David Hadley, CEO, Mediclinic Middle East, said: “It is our great privilege to work with DHCA and MBRU on this valuable conference, and to highlight the significant impact of disruptive innovation on our healthcare system. At Mediclinic, we are constantly striving to deliver the safest and most accurate healthcare to our patients. In order to achieve this it is important that we, and everybody else involved in healthcare, understands how technological innovation is revolutionising the way we provide our services, embraces it and makes it a reality. Examples of this in practice are the recent first implementations of Mediclinic’s new state-of-the-art electronic health record which will streamline care processes, eliminate duplicate tests, expedite billing and result in a greatly enhanced patient journey. It will also give us the ability to adopt new digital technologies in the future and to remain at the forefront of an ever-changing healthcare environment.”

Dr. Amer Sharif, CEO of DHCA’s Education Sector and Vice Chancellor of MBRU said: “We are delighted to hold the Disruptive Innovation in Healthcare Conference in collaboration with our clinical academic affiliates Mediclinic Middle East. At MBRU, our vision is to become a global hub for innovative and integrated healthcare education and research at the service of humanity. We believe that hosting such conferences go in parallel with our vision; we empower our medical students to learn about how innovation and medicine are interlinked through a number of courses. The UAE at large and the city of Dubai are known to be international platforms for innovative ideas in several areas, especially healthcare. We’re happy to welcome a number of local and internationally renowned speakers to MBRU today to discuss and explore the topics of artificial intelligence, precision medicine, Blockchain, and much more. We’re also thankful to DHCA’s visionary Leadership for their immense support to innovation.”

The conference has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 6 European CME credits and locally by Dubai Healthcare City Regulatory for 6 CPD points.

About Mediclinic Middle East

Mediclinic Middle East is part of Mediclinic International, a private hospital group founded in 1983 that today has three operating platforms in Southern Africa (South Africa and Namibia), Switzerland and the United Arab Emirates. The Group also has a 29.9% shareholding in Spire Healthcare, a UK-based healthcare group with 38 hospitals. The foundation of Mediclinic International lies in the application of rigorous science to improve the lives of patients, through the use of state-of-the-art treatments and technologies to care for patients in an evidence-based environment.

Mediclinic Middle East operates seven hospitals, including the newly-opened Mediclinic Parkview Hospital in Dubai, and over 20 clinics with almost 900 inpatient beds in the United Arab Emirates.

About Mohammed Bin Rashid University of Medicine and Health Sciences:

Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) is Dubai Healthcare City’s first medical university which aims to be a global hub for innovative and integrated healthcare education and research at the service of humanity.

MBRU offers undergraduate and postgraduate degrees through its two colleges, Hamdan Bin Mohammed College of Dental Medicine (HBMCDM); the first college established under MBRU, which has a number of specialty dental postgraduate programs. The second college of the university is the College of Medicine for undergraduate medical students offering a Bachelor of Medicine and Bachelor of Surgery program.

MBRU’s MBBS program is a six-year Bachelor of Medicine and Bachelor of Surgery program, were students benefit from a homegrown curriculum, a student-centered medical education, diverse faculty-body, innovative facilities with fully-equipped multi-disciplinary labs (research and anatomy), a comprehensive medical library, and the UAE’s largest simulation center. At MBRU, we empower our students to innovate, research, empathize and lead to serve humanity.

Our mission at MBRU is to advance health in the UAE and the region, through an innovative and integrated academic health system, that is nationally responsive and globally connected, serving individuals and communities.

Queen's University Belfast is MBRU’s international academic partner. The partnership includes quality assurance in the provision of advice and guidance on curriculum development, recruitment of staff, student selection, and admissions, among other areas.

MBRU continues its commitment to develop healthcare professionals for the UAE to compliment the Dubai Plan 2021 and UAE’s 2021 vision. Through MBRU’s rigorous MBBS program, the university aims to produce a high-caliber of physicians and healthcare leaders who will serve the people, society, enhance their experience, make Dubai a destination of choice and contribute positively to the economy thus creating a ‘City of Happy, Creative and Empowered People’ and ‘Smart and Sustainable City’.

For more info, visit www.mbruniversity.ac.ae 

Contact:

Mohammad Akkawi

Action UAE

Tel: +971553941044

Email: mohammad.a[at]actionprgroup.com 

Arun Avamil

Mediclinic Middle East

Tel: + 97145508820

Email: info[at]mediclinic.ae

© Press Release 2018

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.

More From Press Releases